These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 14706054)

  • 1. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
    Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
    Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
    Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
    Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan.
    Sasaki A; Horiuchi N; Hasegawa K; Uehara M
    Diabetes Res Clin Pract; 1995 Jan; 27(1):77-83. PubMed ID: 7781497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Dulbecco CA; Reaven GM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):366-373. PubMed ID: 28254109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
    Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
    Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B; Voigt W; Nobel W; Janka HU
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
    Kuusisto J; Lempiäinen P; Mykkänen L; Laakso M
    Diabetes Care; 2001 Sep; 24(9):1629-33. PubMed ID: 11522711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2.
    Bhatti GK; Bhadada SK; Vijayvergiya R; Mastana SS; Bhatti JS
    J Diabetes Complications; 2016; 30(1):72-8. PubMed ID: 26271411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Diabetologia; 1993 Nov; 36(11):1175-84. PubMed ID: 8270133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
    Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
    J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome.
    Darroudi S; Fereydouni N; Tayefi M; Ahmadnezhad M; Zamani P; Tayefi B; Kharazmi J; Tavalaie S; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mohammadpour AH; Esmaily H; Ghayour-Mobarhan M
    Biofactors; 2019 Jan; 45(1):35-42. PubMed ID: 30561055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?
    Yasuda T; Matsuhisa M; Fujiki N; Sakamoto F; Tsuji M; Fujisawa N; Kimura M; Ishibashi R; Kaneto H; Yamasaki Y; Watarai T; Imano E
    Endocr J; 2007 Dec; 54(5):695-702. PubMed ID: 17785919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.